199 related articles for article (PubMed ID: 22246839)
21. [Epstein-Barr virus penetration mechanism to T lymphoblastoid cell lines].
Uno M
Nihon Rinsho; 1997 Feb; 55(2):404-8. PubMed ID: 9046832
[TBL] [Abstract][Full Text] [Related]
22. Latent membrane protein 1 of Epstein-Barr virus plays an important role in the serum starvation resistance of Epstein-Barr virus-immortalized B lymphocytes.
Park CH; Kim HR; Kim J; Jang SH; Lee KY; Chung GH; Jang YS
J Cell Biochem; 2004 Mar; 91(4):777-85. PubMed ID: 14991769
[TBL] [Abstract][Full Text] [Related]
23. Cross talk between EBV and telomerase: the role of TERT and NOTCH2 in the switch of latent/lytic cycle of the virus.
Giunco S; Celeghin A; Gianesin K; Dolcetti R; Indraccolo S; De Rossi A
Cell Death Dis; 2015 May; 6(5):e1774. PubMed ID: 26018735
[TBL] [Abstract][Full Text] [Related]
24. hTERT inhibits the Epstein-Barr virus lytic cycle and promotes the proliferation of primary B lymphocytes: implications for EBV-driven lymphomagenesis.
Terrin L; Dolcetti R; Corradini I; Indraccolo S; Dal Col J; Bertorelle R; Bonaldi L; Esposito G; De Rossi A
Int J Cancer; 2007 Aug; 121(3):576-87. PubMed ID: 17417773
[TBL] [Abstract][Full Text] [Related]
25. The lytic phase of epstein-barr virus requires a viral genome with 5-methylcytosine residues in CpG sites.
Kalla M; Göbel C; Hammerschmidt W
J Virol; 2012 Jan; 86(1):447-58. PubMed ID: 22031942
[TBL] [Abstract][Full Text] [Related]
26. Oxidative stress enables Epstein-Barr virus-induced B-cell transformation by posttranscriptional regulation of viral and cellular growth-promoting factors.
Chen X; Kamranvar SA; Masucci MG
Oncogene; 2016 Jul; 35(29):3807-16. PubMed ID: 26592445
[TBL] [Abstract][Full Text] [Related]
27. Quantitative evaluation of the role of Epstein-Barr virus immediate-early protein BZLF1 in B-cell transformation.
Katsumura KR; Maruo S; Wu Y; Kanda T; Takada K
J Gen Virol; 2009 Oct; 90(Pt 10):2331-2341. PubMed ID: 19553389
[TBL] [Abstract][Full Text] [Related]
28. BZLF1 Attenuates Transmission of Inflammatory Paracrine Senescence in Epstein-Barr Virus-Infected Cells by Downregulating Tumor Necrosis Factor Alpha.
Long X; Li Y; Yang M; Huang L; Gong W; Kuang E
J Virol; 2016 Sep; 90(17):7880-93. PubMed ID: 27334596
[TBL] [Abstract][Full Text] [Related]
29. HLA-restricted presentation of WT1 tumor antigen in B-lymphoblastoid cell lines established using a maxi-EBV system.
Kanda T; Ochi T; Fujiwara H; Yasukawa M; Okamoto S; Mineno J; Kuzushima K; Tsurumi T
Cancer Gene Ther; 2012 Aug; 19(8):566-71. PubMed ID: 22722376
[TBL] [Abstract][Full Text] [Related]
30. AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome.
Kalla M; Schmeinck A; Bergbauer M; Pich D; Hammerschmidt W
Proc Natl Acad Sci U S A; 2010 Jan; 107(2):850-5. PubMed ID: 20080764
[TBL] [Abstract][Full Text] [Related]
31. Human herpesvirus 6 variant A, but not variant B, infects EBV-positive B lymphoid cells, activating the latent EBV genome through a BZLF-1-dependent mechanism.
Cuomo L; Angeloni A; Zompetta C; Cirone M; Calogero A; Frati L; Ragona G; Faggioni A
AIDS Res Hum Retroviruses; 1995 Oct; 11(10):1241-5. PubMed ID: 8573381
[TBL] [Abstract][Full Text] [Related]
32. STAT1 contributes to the maintenance of the latency III viral programme observed in Epstein-Barr virus-transformed B cells and their recognition by CD8+ T cells.
McLaren JE; Zuo J; Grimstead J; Poghosyan Z; Bell AI; Rowe M; Brennan P
J Gen Virol; 2009 Sep; 90(Pt 9):2239-50. PubMed ID: 19439556
[TBL] [Abstract][Full Text] [Related]
33. Dithiocarbamates and viral IL-10 collaborate in the immortalization and evasion of immune response in EBV-infected human B lymphocytes.
Irons RD; Le AT
Chem Biol Interact; 2008 Mar; 172(1):81-92. PubMed ID: 18163983
[TBL] [Abstract][Full Text] [Related]
34. Induction of interferon-stimulated genes on the IL-4 response axis by Epstein-Barr virus infected human b cells; relevance to cellular transformation.
Smith N; Tierney R; Wei W; Vockerodt M; Murray PG; Woodman CB; Rowe M
PLoS One; 2013; 8(5):e64868. PubMed ID: 23724103
[TBL] [Abstract][Full Text] [Related]
35. Roles of lytic viral infection and IL-6 in early versus late passage lymphoblastoid cell lines and EBV-associated lymphoproliferative disease.
Jones RJ; Seaman WT; Feng WH; Barlow E; Dickerson S; Delecluse HJ; Kenney SC
Int J Cancer; 2007 Sep; 121(6):1274-81. PubMed ID: 17520680
[TBL] [Abstract][Full Text] [Related]
36. CD4+ T cells inhibit growth of Epstein-Barr virus-transformed B cells through CD95-CD95 ligand-mediated apoptosis.
Wilson AD; Redchenko I; Williams NA; Morgan AJ
Int Immunol; 1998 Aug; 10(8):1149-57. PubMed ID: 9723701
[TBL] [Abstract][Full Text] [Related]
37. Novel expression and regulation of TIMP-1 in Epstein Barr virus-infected cells and its impact on cell survival.
Lin SJ; Wu SW; Chou YC; Lin JH; Huang YC; Chen MR; Ma N; Tsai CH
Virology; 2015 Jul; 481():24-33. PubMed ID: 25765004
[TBL] [Abstract][Full Text] [Related]
38. Dynamic Epstein-Barr virus gene expression on the path to B-cell transformation.
Price AM; Luftig MA
Adv Virus Res; 2014; 88():279-313. PubMed ID: 24373315
[TBL] [Abstract][Full Text] [Related]
39. Interactions involving cyclosporine A, interleukin-6, and Epstein-Barr virus lead to the promotion of B-cell lymphoproliferative disease.
Tanner JE; Alfieri C
Leuk Lymphoma; 1996 May; 21(5-6):379-90. PubMed ID: 9172802
[TBL] [Abstract][Full Text] [Related]
40. Functional Epstein-Barr virus reservoir in plasma cells derived from infected peripheral blood memory B cells.
Al Tabaa Y; Tuaillon E; Bollore K; Foulongne V; Petitjean G; Seigneurin JM; Duperray C; Desgranges C; Vendrell JP
Blood; 2009 Jan; 113(3):604-11. PubMed ID: 18845794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
